Pharma companies are highly matrixed organizations, which presents challenges in handoffs, overlaps between roles and functions, access to data and accountability of who owns and acts on this data in a timely manner. Therefore, instigating change at an organizational level is difficult, and takes much longer than anticipated. This podcast will share insights and experiences from Ozgun Demir, Head of Digital Marketing at Genentech on:

• Change management, resource management: how you ready the organization to take in whatever capabilities you're building
• Data and measurement: ensuring marketers get access to the data in a timely manner
• Accountability: ensuring overlapping roles act efficiently and expediently both with data and technology
• Enacting a learning agenda: Genentech's approach to ensuring everyone - at an enterprise level - understands the same language, terminology and definitions
• In-housing of media vs. moving therapeutic area level of engagement to an enterprise level of engagement

Toxic Portraits:

Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged. Plus, given today's budget realities, you're likely being asked to achieve more with less. In this podcast, William Grambley, CEO of AllazoHealth, explains how pharma marketers can reach their omni-channel engagement objectives with artificial intelligence (AI), anticipate patient intent, and drive next-best-action at the individual level. With AI, pharma marketers can finally truly personalize campaigns, increase therapy initiation and medication adherence, and deliver marketing operations efficiency at scale.

Tune in to this episode of the Pharma Marketing Podcast for a deeper dive into pharma and modular content, with Ryan Rosenberg, Director Omnichannel Capabilities @ Sanofi, who shared his insights on making modular content work and why pharma is the perfect candidate for it.

Tune in to this episode, Law Changes and Updates: What Pharma Marketers Need to Know, with our friend and Editorial Advisory Board member and returning guest, Darshan Kulkarni, Attorney of Law at the Kulkarni Law Firm which advises life science companies and their advisors including marketing and PR agencies with compliance issues, promotional review, audits and training. He is also a Pharmacist, Book Author and Professor, and host of the world famous Darshantalks podcast which focuses on emerging life science issues. He is joined by the incomparable Jennifer Ginest, Digital Marketing Manager at the Pharma Marketing Network. Find out what law and regulation changes could impact your brand now and in the future.

Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN discuss the current role of Digital Therapeutics in Healthcare and were it is headed.

Tune in to this episode of the PMN podcast to hear from our guest, Robert Schildt, Senior Director of Go-To-Market Innovation at Biohaven Pharmaceuticals and Jennifer Ginest, Digital Marketing Manager of PMN discuss how digital is being used to engage and personalize the CX experience in pharma.

In this podcast interview, R.J. Lewis talks with David Hunt, the CEO of the independent agency, The Considered, about how they are breaking the rules in pharma advertising.

David discusses and answers questions around:

• How The Considered is different.
• What launched the conception of the agency?
• What rules is The Considered breaking?
• The new working normal and how The Considered is leveraging it for successful outcomes for their clients and their audiences.